Toth Financial Advisory Corp Spero Therapeutics, Inc. Transaction History

Toth Financial Advisory Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.74 - $7.44 $127 - $1,279	-172 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$13.23 - $21.48 $2,275 - $3,694	172 New	172 $3,000
Q3 2020 Oct 16, 2020	SELL	$8.96 - $14.12 $1,541 - $2,428	-172 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$7.27 - $14.18 $1,250 - $2,438	172 New	172 $2,000
Q4 2019 Jan 27, 2020	SELL	$9.46 - $12.16 $1,419 - $1,824	-150 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$9.01 - $12.55 $1,351 - $1,882	150 New	150 $2,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.